Review
doi: 10.1056/NEJMra1810772.Pituitary-Tumor Endocrinopathies
Affiliations
- PMID:32130815
- DOI: 10.1056/NEJMra1810772
Item in Clipboard
Review
Pituitary-Tumor Endocrinopathies
Shlomo Melmed. N Engl J Med..
Display options
Format
Display options
Format
No abstract available
Similar articles
- The characteristics of acromegalic patients with hyperprolactinemia and the differences with hyperprolactinemia patients.Huan C, Cui G, Ren Z.Huan C, et al.Pak J Pharm Sci. 2015 Mar;28(2 Suppl):713-8.Pak J Pharm Sci. 2015.PMID:25796163
- [New developments in pituitary diseases].Gruber M, Willenberg HS, Bornstein SR.Gruber M, et al.Dtsch Med Wochenschr. 2012 Dec;137(49):2540-2. doi: 10.1055/s-0032-1327285. Epub 2012 Nov 27.Dtsch Med Wochenschr. 2012.PMID:23188633Review.German.No abstract available.
- Combined acromegaly and subclinical Cushing disease related to high-molecular-weight adrenocorticotropic hormone.Oki K, Yamane K, Oda Y, Kamei N, Watanabe H, Tominaga A, Amatya VJ, Oki Y, Kohno N.Oki K, et al.J Neurosurg. 2009 Feb;110(2):369-73. doi: 10.3171/2008.8.JNS08154.J Neurosurg. 2009.PMID:18991502
- Different imaging characteristics of concurrent pituitary adenomas in a patient with Cushing's disease.Mehta GU, Montgomery BK, Raghavan P, Sharma S, Nieman LK, Patronas N, Oldfield EH, Chittiboina P.Mehta GU, et al.J Clin Neurosci. 2015 May;22(5):891-4. doi: 10.1016/j.jocn.2015.01.001. Epub 2015 Mar 29.J Clin Neurosci. 2015.PMID:25827866Free PMC article.
- Pituitary adenoma and concomitant Rathke's cleft cyst.Noh SJ, Ahn JY, Lee KS, Kim SH.Noh SJ, et al.Acta Neurochir (Wien). 2007 Dec;149(12):1223-8. doi: 10.1007/s00701-007-1295-x. Epub 2007 Oct 3.Acta Neurochir (Wien). 2007.PMID:17914599Review.
Cited by
- A Non-Secreting Pituitary Adenoma That Changed to a Prolactinoma.Santiago-Vazquez C, Palacios-Paino N, Cordido F.Santiago-Vazquez C, et al.Clin Pract. 2024 Jul 4;14(4):1310-1318. doi: 10.3390/clinpract14040106.Clin Pract. 2024.PMID:39051300Free PMC article.
- A novel human tumoroid 3D model of sustained ACTH-secreting cell cultures to study critically needed therapies for Cushing's disease.Fuentes-Fayos AC, Luque RM.Fuentes-Fayos AC, et al.EBioMedicine. 2021 May;67:103368. doi: 10.1016/j.ebiom.2021.103368. Epub 2021 May 13.EBioMedicine. 2021.PMID:33993049Free PMC article.No abstract available.
- CircDDX17 inhibits invasive progression of pituitary adenomas by sponging miR-1279 and regulating CADM2 expression.Yue X, Lan F, Liu W.Yue X, et al.Front Oncol. 2023 Nov 1;13:1268644. doi: 10.3389/fonc.2023.1268644. eCollection 2023.Front Oncol. 2023.PMID:38023219Free PMC article.
- Hypopituitarism, Diabetes Insipidus, and Syndrome of Inappropriate Antidiuretic Hormone Secretion after Pituitary Macroadenoma Surgery with Indocyanine Green Dye.Felbabić T, Velnar T, Kocjan T.Felbabić T, et al.Diagnostics (Basel). 2024 Aug 26;14(17):1863. doi: 10.3390/diagnostics14171863.Diagnostics (Basel). 2024.PMID:39272648Free PMC article.
- Plurihormonal Pituitary Neuroendocrine Tumors: Clinical Relevance of Immunohistochemical Analysis.Dumitriu-Stan RI, Burcea IF, Dobre R, Nastase VN, Ceausu RA, Raica M, Poiana C.Dumitriu-Stan RI, et al.Diagnostics (Basel). 2024 Jan 11;14(2):170. doi: 10.3390/diagnostics14020170.Diagnostics (Basel). 2024.PMID:38248047Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical